Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00091_DB01098_nanopub.RAB1DeQXiYcVOBoBqf8AlkGkNOI8XRPBqd_1vH-BqSaro#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00091_DB01098 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00091_DB01098 label "DDI between Cyclosporine and Rosuvastatin - Cyclosporine may increase the serum concentration of rosuvastatin. Limit rosuvastatin dosing to 5 mg/day and monitor for changes in the therapeutic and adverse effects of rosuvastatin if cyclosporine is initiated, discontinued or dose changed. [drugbank_resource:DB00091_DB01098]" assertion.
- drugbank_resource:DB00091_DB01098 identifier "drugbank_resource:DB00091_DB01098" assertion.
- drugbank_resource:DB00091_DB01098 title "DDI between Cyclosporine and Rosuvastatin - Cyclosporine may increase the serum concentration of rosuvastatin. Limit rosuvastatin dosing to 5 mg/day and monitor for changes in the therapeutic and adverse effects of rosuvastatin if cyclosporine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00091 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00091_DB01098 assertion.
- drugbank:DB01098 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00091_DB01098 assertion.